Home » Topics » Respiratory, BioWorld Science

Respiratory, BioWorld Science
RSS

PDE IV inhibitors claimed by Euroceltique

Aug. 16, 1996

Roche Bioscience, LeukoSite to investigate drugs for allergy and asthma

Aug. 16, 1996

Ipratropium bromide relieves rhinorrhea, sneezing in cold patients

Aug. 16, 1996

Cyclohexapeptides with multiple utilities reported by Hoechst

Aug. 9, 1996

Serine protease inhibitors in Teijin's R&D pipeline

Aug. 9, 1996

Potent 5-lipoxygenase inhibitors from Yakult Honsha

Aug. 9, 1996

Alliance signed for asthma disease management program

Aug. 9, 1996

Hoechst Marion Roussel receives marketing approval for Allegra

Aug. 9, 1996

Raloxifene claimed as treatment for excess bradykinin-related conditions

July 26, 1996

Leukocyte elastase inhibitors reported by Sanofi Winthrop

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 7, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 7, 2024.
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...
Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity
BioWorld
After missing out on the glucagon-like peptide 1 obesity market, Sanofi SA is prospecting for next-generation drugs and is making a strategic equity investment in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.